Investing

RAD Granted US FDA Fast Track for RAD101 Metastases Imaging

by admin
RAD Granted US FDA Fast Track for RAD101 Metastases Imaging

Radiopharm Theranostics (RAD:AU) has announced RAD Granted US FDA Fast Track for RAD101 Metastases Imaging

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Horne 5 Project Update

March 26, 2025

A$20 Million Placement to Strategic Partner

June 20, 2025

Lithium Market 2025 Year-End Review

December 23, 2025

Nuvau Launches Follow up Drilling to Bracemac Footwall...

August 12, 2025

American Uranium LimitedLo Herma Resource Expansion Drilling Approved

September 26, 2025

Editor’s Picks: Marathon Project Gets Nod, Rio Tinto...

June 7, 2025

Basin Energy LtdInvestor Webinar and Presentation

August 27, 2025

CORRECTED: CHARBONE Hydrogen is Acquiring Hydrogen Production Assets...

September 6, 2025

WPIC: Platinum Market Set for 2026 Stability After...

November 22, 2025

Alvopetro Announces an Operational Update, Q1 2025 Financial...

May 8, 2025